HomeMARKSANS • NSE
add
Marksans Pharma Ltd
Previous close
₹182.79
Day range
₹181.40 - ₹185.90
Year range
₹162.00 - ₹308.00
Market cap
82.63B INR
Avg Volume
823.94K
P/E ratio
23.47
Dividend yield
0.44%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 7.20B | 12.23% |
Operating expense | 2.94B | 10.06% |
Net income | 982.50M | 1.59% |
Net profit margin | 13.64 | -9.49% |
Earnings per share | — | — |
EBITDA | 1.43B | 4.73% |
Effective tax rate | 25.65% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.67B | -0.70% |
Total assets | 34.42B | 18.23% |
Total liabilities | 7.28B | 20.17% |
Total equity | 27.14B | — |
Shares outstanding | 452.76M | — |
Price to book | 3.08 | — |
Return on assets | — | — |
Return on capital | 10.04% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 982.50M | 1.59% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1992
Website
Employees
1,840
